HER2 Expression in Salivary Gland Carcinomas
Bonnie S. Glisson(The University of Texas MD Anderson Cancer Center), Marshall R. Posner(Icahn School of Medicine at Mount Sinai), Jeoffrey Krane(Dana-Farber Cancer Institute), Carmen Summey(The University of Texas MD Anderson Cancer Center), A. Dimitrios Colevas(Cancer Institute (WIA)), Adel K. El‐Naggar(Barking, Havering And Redbridge University Hospitals NHS Trust), Matthew A. Arquette(Washington University in St. Louis), Corey J. Langer(University of Pennsylvania), Rosemary Costello(Dana-Farber Cancer Institute), Merrill S. Kies(The University of Texas MD Anderson Cancer Center), Robert I. Haddad(Georgetown University), Philip C. Amrein(Massachusetts General Hospital)
Cited by 202
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>
|Science|2011|1.7k
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k